Plasma and Aqueous Humor Angiotensin-Converting Enzyme Levels in Patients with Diabetic Retinopathy

被引:14
作者
Aydin, Erdinc [1 ]
Demir, Helin Deniz [1 ]
Sahin, Semsettin [2 ]
机构
[1] Gaziosmanpasa Univ, Fac Med, Dept Ophthalmol, Tokat, Turkey
[2] Gaziosmanpasa Univ, Fac Med, Dept Biochem, Tokat, Turkey
关键词
Angiotensin-converting enzyme; Aqueous humor; Diabetes mellitus; Diabetic retinopathy; Retinal angiogenesis; Plasma; ENDOTHELIAL GROWTH-FACTOR; VITREOUS FLUID; RETINAL NEOVASCULARIZATION; RENIN; INHIBITION; EXPRESSION; SYSTEM; COMPLICATIONS; CANDESARTAN; PROGRESSION;
D O I
10.3109/02713680903484242
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To assess angiotensin-converting enzyme (ACE) levels in aqueous humor and plasma of patients with nonproliferative diabetic retinopathy (NPDR) and proliferative diabetic retinopathy (PDR) as another potent ischemia-induced angiogenic factor. Methods: The clinical comparative study included 40 patients with diabetic retinopathy and 16 healthy subjects. For all patients, aqueous humors were collected during the cataract surgery or intravitreal injection of triamcinolone acetonide. ACE levels were measured using a solid-phase chemiluminescence immunoassay. Results: We observed significantly elevated ACE level in aqueous humor of patients with PDR compared with the patients with NPDR and normal subjects (P = 0.023), but no significant difference was detected between nonproliferative diabetics and control group (P = 0.239). There was no significant difference in plasma ACE levels among diabetic and control groups (P = 0.816). Conclusion: Elevated ACE level may induce retinal angiogenesis and proliferative retinopathy in patients with DM. We consider that high levels of ACE in aqueous humor can reflect the association between retinal angiogenesis and DM serve as predictor in the progression of diabetic retinopathy.
引用
收藏
页码:230 / 234
页数:5
相关论文
共 31 条
[1]   SUPPRESSION OF RETINAL NEOVASCULARIZATION IN-VIVO BY INHIBITION OF VASCULAR ENDOTHELIAL GROWTH-FACTOR (VEGF) USING SOLUBLE VEGF-RECEPTOR CHIMERIC PROTEINS [J].
AIELLO, LP ;
PIERCE, EA ;
FOLEY, ED ;
TAKAGI, H ;
CHEN, H ;
RIDDLE, L ;
FERRARA, N ;
KING, GL ;
SMITH, LEH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (23) :10457-10461
[2]   VASCULAR ENDOTHELIAL GROWTH-FACTOR IN OCULAR FLUID OF PATIENTS WITH DIABETIC-RETINOPATHY AND OTHER RETINAL DISORDERS [J].
AIELLO, LP ;
AVERY, RL ;
ARRIGG, PG ;
KEYT, BA ;
JAMPEL, HD ;
SHAH, ST ;
PASQUALE, LR ;
THIEME, H ;
IWAMOTO, MA ;
PARK, JE ;
NGUYEN, HV ;
AIELLO, LM ;
FERRARA, N ;
KING, GL .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (22) :1480-1487
[3]  
[Anonymous], 1991, Ophthalmology, V98, P786
[4]   Randomised placebo-controlled trial of lisinopril in normotensive patients with insulin-dependent diabetes and normoalbuminuria or microalbuminuria [J].
Chaturvedi, N ;
Stevenson, J ;
Fuller, JH ;
Rottiers, R ;
Ferriss, B ;
Karamanos, B ;
Kofinis, A ;
Petrou, C ;
IonescuTirgovisite, C ;
Iosif, C ;
Tamas, G ;
Bibok, G ;
Kerenyi, Z ;
KisGombos, P ;
Toth, J ;
Grealy, G ;
Priem, H ;
Koivisto, V ;
Tuominen, J ;
Kostamo, E ;
IdziorWalus, B ;
Solnica, B ;
GalickaLatalie, D ;
Michel, G ;
Keipes, M ;
Giuliani, A ;
Herode, A ;
Santeusanio, F ;
Bueti, A ;
Bistoni, S ;
Cagini ;
Navalesi, R ;
Penno, G ;
Nannipieri, M ;
Rizzo, L ;
Miccoli, R ;
Ghirlanda, G ;
Cotroneo, P ;
Manto, A ;
Minella, A ;
Saponara, C ;
Ward, J ;
Plater, M ;
Ibrahim, S ;
Ibbotson, S ;
Mody, C ;
Papazoglou, N ;
Manes, C ;
Soulis, K ;
Voukias, M .
LANCET, 1997, 349 (9068) :1787-1792
[5]   Circulating plasma vascular endothelial growth factor and microvascular complications of Type 1 diabetes mellitus: the influence of ACE inhibition [J].
Chaturvedi, N ;
Fuller, JH ;
Pokras, F ;
Rottiers, R ;
Papazoglou, N ;
Aiello, LP .
DIABETIC MEDICINE, 2001, 18 (04) :288-294
[6]   Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials [J].
Chaturvedi, Nish ;
Porta, Massimo ;
Klein, Ronald ;
Orchard, Trevor ;
Fuller, John ;
Parving, Hans Henrik ;
Bilous, Rudy ;
Sjolie, Anne Katrin .
LANCET, 2008, 372 (9647) :1394-1402
[7]   RENIN, PRORENIN, AND IMMUNOREACTIVE RENIN IN VITREOUS FLUID FROM EYES WITH AND WITHOUT DIABETIC-RETINOPATHY [J].
DANSER, AHJ ;
VANDENDORPEL, MA ;
DEINUM, J ;
DERKX, FHM ;
FRANKEN, AAM ;
PEPERKAMP, E ;
DEJONG, PTVM ;
SCHALEKAMP, MADH .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1989, 68 (01) :160-167
[8]  
DANSER AHJ, 1994, INVEST OPHTH VIS SCI, V35, P1008
[9]   REGULATION OF TISSUE RENIN AND ANGIOTENSIN GENE EXPRESSIONS [J].
DZAU, VJ ;
INGELFINGER, JR ;
PRATT, RE .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1986, 8 :S11-S16
[10]   SERUM ANGIOTENSIN-CONVERTING ENZYME IN DIABETIC-PATIENTS [J].
FEMAN, SS ;
MERICLE, RA ;
REED, GW ;
MAY, JM ;
WORKMAN, RJ .
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1993, 305 (05) :280-284